Interleukin 10 (IL-10), originally identified as a TH2 helper T-cell product able to inhibit cytokine production by THI cells, is highly homologous to BCRF1 
associated with some types of delayed-type hypersensitivity (5) , whereas TH2 clones, producing IL4 and IL-5, are associated with humoral responses (6) . Furthermore, TH2 cells have been found to specifically produce a cytokine inhibiting the synthesis of several cytokines by THO clones.
This cytokine, first called cytokine synthesis inhibitory factor (CSIF), has since been renamed IL-10 (7) (8) (9) .
Mouse and human IL-10 display a high sequence similarity with an open reading frame in the Epstein-Barr virus (EBV), BCRF1 (8) , coding for a putative protein expressed in the late viral lytic cycle (ref. 10 ; G. S. Hudson, D.-H.H., and K.W.M., unpublished results). Even if the product of the BCRF1 gene, viral IL-10 (vIL-10), does not display all the properties described for IL-10, it has retained from cellular IL-10 the capacity to block cytokine synthesis, a function that could give a selective advantage to EBV (7, 9, 11, 12) . A common feature shared by TH2 cells and EBV is their capacity to stimulate B-cell activation, proliferation, and antibody production (1, 2, 6, 13) . Therefore, we speculated that aspects of this phenomenon might be mediated by both types of IL-10. Accordingly, we studied the effects of recombinant human IL-10 (hIL-10) and vIL-10 on the proliferation and differentiation of human B cells activated via their antigen receptors (surface immunoglobulin) or via their CD40 antigen (14, 15) .
MATERIALS AND METHODS
Reagents. The anti-CD40 monoclonal antibody mAb89 was produced in the laboratory (16) . The CDw32/Fcy receptor I-transfected thymidine kinase-negative L-cell line (CDw32 L cells) was described earlier (17) . Formalin-fixed Staphylococcus aureus strain Cowan (SAC) (Pansorbin) was from Calbiochem, and anti-IgM antibodies coupled to beads (anti-IL)
were purchased from Bio-Rad. Cell phenotype was determined using fluorescein-conjugated monoclonal antibodies from Becton Dickinson. Cultures were incubated in modified Iscove's medium as detailed previously (18) .
B-Cell Preparations and Cell Cultures. B cells were isolated from tonsils as previously described (19) . Briefly, after a resetting step with sheep red blood cells, non-rosetting cells were further incubated with anti-CD2, anti-CD3, and anti-CD14 monoclonal antibodies prior to negative selection performed with magnetic beads coated with anti-mouse IgG (Dynabeads, Dynal, Oslo). In the isolated cell population, >98% expressed CD19 or CD20 (B cells) and <1% expressed CD2 (T cells) or CD14 (monocytes).
Assays for preactivated B cells. B lymphocytes, adjusted to 1 x 106 cells per ml, were stimulated for 48 hr by insolubilized anti-IL (5 ,ug/ml) or SAC (0.01% final dilution) as described (19 tTo whom reprint requests should be addressed.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. Cytokines. Purified recombinant hIL-2 (Amgen; 3 x 106 units/ml) and hIL-4 (Schering-Plough; 107 units/mg) were used at 10 and 50 units/ml, respectively. Recombinant hIL-10 and vIL-10 or their respective mock controls were culture supernatants from COS-7 transfectants. Purified recombinant h/vIL-10 from Escherichia coli material was obtained as described by de Waal Malefyt et al. (12) . Based on an IL-10-specific ELISA, COS-7 transfectant supernatants contained IL-10 at 0.6-1.2 ,g/ml and, for comparable concentrations, gave biological activities similar to those generated with the purified E. coli-derived material.
RESULTS
hIL-10 and vIL-10 Are Potent Growth Factors for Activated B Lymphocytes. Recombinant hIL-10 and vIL-10, in the form of COS-7 transfectant supernatants or E. coli-derived purified proteins, were added to highly purified human B lymphocytes activated via surface immunoglobulin (SAC or anti-it) or via CD40 antigen (anti-CD40 mAb89 and CDw32-transfected mouse L cells) (14, 15) . As shown in Table 1 , hIL-10 as well as vIL-10 enhanced [3H]thymidine incorporation of human B lymphocytes activated through ligation of surface immunoglobulin by SAC or anti-,u, whereas it was ineffective on B cells cultured without polyclonal activator. Dose-response analysis with pure products (data not shown) indicated that the two cytokines displayed stimulating effects with similar amplitude. Yet even at optimal concentrations, the h/vIL-10-induced levels of [3H]thymidine incorporation were always lower than those mediated by IL-2 or IL-4.
When B cells were activated in the CD40 system, h/vIL-10 showed a strong costimulatory effect on DNA replication (Table 2 ). In these culture conditions, the B-cell growthpromoting effects of IL-10 and IL-4 were comparable, whereas IL-2 was virtually inactive. The proliferative effects of purified E. coli-derived hIL-10 and vIL-10 were dose- of mAb89 (0.5 Ag/ml), or both. hIL-10 and vIL-10 were used at 10 ng/ml as COS-7 transfectant supernatants. Control supernatant was inactive. IL-2 and IL-4 were used at 10 and 50 units/ml, respectively. Cells were harvested at day 7. Results are means ± SD of triplicates. dependent and comparable (Fig. 1A) . IL-10 (both human and viral) acted in combination with IL-4 to induce strong B-cell growth. In both cases, a plateau was reached at 10 ng/ml. As demonstrated by kinetic studies (Fig. 1B) , the B-cell growth effects of IL-4 and h/vIL-10, which started at day 3, were quite comparable until day 7, after which DNA replication slowed down with IL-10 but not with IL-4. Moreover, from hIL-10 and vIL-10 Stimulate Immunoglobulin Production of Activated B Lymphocytes. The activity of h/vIL-10 in B-cell differentiation was examined next. As shown in Table 3 , IL-10 induced SAC-preactivated B lymphocytes to produce high levels of IgM, IgG, and IgA. hIL-10 and vIL-10 gave similar results. Moreover, IL-10 appeared to be more potent than either IL-2 or IL-4, cytokines considered, until now, as the most efficient in this culture system (21) .
When B lymphocytes were activated in the CD40 system, addition of IL-10 resulted in the production of considerable amounts of IgM, IgG, and IgA (Table 4) . As observed with SAC-activated cells, IL-10 was much more efficient than either IL-2 or IL-4. The IL-lO-induced immunoglobulin production was dose-related, with maximal immunoglobulin production and cell proliferation obtained for the same h/vIL-10 concentrations (data not shown). Unlike IL-4, neither vIL-10 nor hIL-10 induced anti-CD40-activated B .tg/ml). hIL-10 and vIL-10 were used at 10 ng/ml as COS-7 transfectant supernatants. Control supernatant was inactive. IL-2 and IL-4 were used at 10 and 50 units/ml, respectively. Supernatants were harvested at day 10 and immunoglobulin levels were determined by ELISA. Results are means ± SD of triplicate determinations.
lymphocytes to secrete IgE. The four isotypes were detected when IL-4 and IL-10 were added simultaneously. However, whereas the combination of IL-4 and IL-10 had additive effects on B-cell proliferation, the levels of secreted IgM, IgG, and IgA were lower than those observed with IL-10 alone (Table 4) . Addition of IL-4 at only 1 unit/ml resulted in a 50% decrease of the IL-10-induced IgM, IgG, and IgA production ( entiation of activated human B lymphocytes. This demonstration of an effect of IL-10 on B cells is consistent with the reported enhancing effect of IL-10 on the viability and the Ia antigen expression of resting murine B cells (22) . The proliferative effects of IL-10 on B cells activated through their antigen receptors were slightly smaller than those of either IL-2 or IL-4. However, when tested on B cells activated through their CD40 antigen, IL-10 was as potent as IL4 when IL-2 was inactive. As cells that had been proliferating for 10 days with IL-10 and anti-CD40 expressed CD19 and CD20, we conclude that IL-10, IL-2, and IL-4 represent three well-characterized B-cell growth factors, whereas low molecular weight BCGF (23), tumor necrosis factor (24) , and interferon-y (19) may represent cofactors. The most striking activity of IL-10 was its powerful effect on the stimulation of immunoglobulin secretion by activated B cells. When B cells were activated through their antigen receptor (by SAC particles), IL-10 was much more efficient than IL-2 and IL-4. Like IL-2, it induced the secretion of the three isotypes IgM, IgA, and IgG, whereas IL-4 induced the secretion ofonly IgM and IgG (21) . When purified B cells were stimulated in a T-cell-independent fashion through their CD40 antigen, IL-10 induced the secretion of IgM, IgG, and IgA to levels we had never seen before with any cytokine or cytokine combination (15) . ELISPOT assays demonstrated that IL-10 induced virtually all anti-CD40-activated B cells to secrete immunoglobulin. However, unlike IL-4, IL-10 was not able to induce the production of IgE (15, 25) . We do not know whether the IL-10-induced IgG and IgA production resulted from the expansion and differentiation of already committed precursors, from isotype switching in the naive B-cell population, or from both. Nor do we know whether IL-10 plays a role in antigen-induced and T-cell-dependent B-cell proliferation and differentiation, and whether excessive IL-10 production may be involved in diseases characterized by excessive B-cell proliferation and differentiation, such as leukemias and autoimmune diseases. It will be particularly relevant to see whether pathological situations linked to EBV infections (infectious mononucleosis, lymphomas, Duncan syndrome) result from excessive IL-10 production. In this context, it will be important to determine whether the intense B-cell proliferation induced by EBV infection could be related to the endogeneous release of IL-10, thus providing, in addition to the inhibition of interferon-y production, another selective advantage for the survival of EBV.
The remarkable proliferation and secretion of all immunoglobulin isotypes by activated B cells in response to the combination of IL-4 and IL-10 may be consistent with the preferential role of TH2 cells in the humoral immune response (1, 2) . In keeping with this, the combination of CD40 trigtion, immunoglobulin secretion, and isotype switching to IgE (and possibly other isotypes) may represent cardinal features of germinal centers of secondary follicles in lymphoid organs (26) . As germinal centers represent the site of antibody affinity maturation through somatic mutations, one may speculate that combinations of anti-CD40, IL-4, and IL-10 may activate the somatic mutation machinery and that addition of antigen to these cultures may result in the selection of B-cell clones producing high-affinity antibodies.
